GlassScriptPhysician profile
Donata Vaiciunaite
NPI 1881134567
$5,159.81
in general payments reported to CMS, 2019-2025
14 companies · $618 in 2025
The $618 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2022: $1,475 · 2023: $19.34 · 2024: $2,922 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272 · Travel and Lodging: $1,219 · Education: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,272.42 |
| Travel and Lodging | $1,218.73 |
| Education | $1,068.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,730.74 | 2022-2025 | |
| Medtronic, INC. | $441.32 | 2022-2024 | Endoflip |
| Davol INC. | $407.46 | 2024-2025 | Phasix Mesh |
| Endogastric Solutions, INC | $153.57 | 2024 | Esophyx |
| Smith+Nephew, INC. | $115.73 | 2022 | |
| Ekos Corporation | $99.10 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Apollo Endosurgery US INC | $35.80 | 2022 | |
| Solventum Corporation | $23.37 | 2025 | Promogran, Activ.A.C. |
| Merck Sharp & Dohme LLC | $20.58 | 2025 | Bridion |
| Pinnacle Biologics, INC | $19.34 | 2023 | Photofrin |
| Medical Device Business Services, INC. | $18.49 | 2022 | |
| Shionogi INC | $14.47 | 2019 | |
| Pfizer INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donata Vaiciunaite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.